Literature DB >> 5345937

Treatment of cardiac arrhythmias with phenytoin.

J D Eddy, S P Singh.   

Abstract

Phenytoin was given intravenously in 37 patients with cardiac arrhythmias-21 had acute myocardial infarction and 16 had other conditions. There was a favourable response in 18 of the 21 cases with acute myocardial infarction, with a return to sinus rhythm in six of the nine cases with supraventricular arrhythmias, and a return to sinus rhythm in 10 of the 12 cases of ventricular arrhythmias, the remaining two showing a significant reduction in the number of ventricular extra-systoles.In the second group of 16 cases which had various causes there was a satisfactory response in only six. Digitalis played no part in producing any of the arrhythmias. Phenytoin was used orally for suppressing and preventing abnormal rhythm in five patients, and three of these responded favourably. The number of patients treated orally is too small to draw any definite conclusion.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5345937      PMCID: PMC1629673          DOI: 10.1136/bmj.4.5678.270

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  TOXICITY OF QUINIDINE.

Authors:  O BRENNER; P H DAVISON; D W EVANS
Journal:  Lancet       Date:  1964-11-28       Impact factor: 79.321

2.  FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS.

Authors:  S ORAM; J P DAVIES
Journal:  Lancet       Date:  1964-06-13       Impact factor: 79.321

3.  Dicoumarol-induced diphenylhydantoin intoxication.

Authors:  J M Hansen; M Kristensen; L Skovsted; L K Christensen
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

4.  Relationship between the plasma level of diphenylhydantoin sodium and its cardiac antiarrhythmic effects.

Authors:  J T Bigger; D H Schmidt; H Kutt
Journal:  Circulation       Date:  1968-08       Impact factor: 29.690

5.  The electrophysiological properties of diphenylhydantoin sodium as compared to procaine amide in the normal and digitalis-intoxicated heart.

Authors:  R H Helfant; B J Scherlag; A N Damato
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

6.  Cardiac and peripheral vascular effects of diphenylhydantoin sodium.

Authors:  C G Mixter; J M Moran; W G Austen
Journal:  Am J Cardiol       Date:  1966-03       Impact factor: 2.778

7.  Diphenylhydantoin in cardiac arrhythmias.

Authors:  M Rosen; R Lisak; I L Rubin
Journal:  Am J Cardiol       Date:  1967-11       Impact factor: 2.778

8.  Effect of diphenylhydantoin on left ventricular function in patients with heart disease.

Authors:  A D Lieberson; R R Schumacher; R H Childress; D L Boyd; J F Williams
Journal:  Circulation       Date:  1967-11       Impact factor: 29.690

9.  Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases.

Authors:  A H Unger; H J Sklaroff
Journal:  JAMA       Date:  1967-04-24       Impact factor: 56.272

  9 in total
  3 in total

1.  Plasma levels of lidocaine during combined treatment with phenytoin and procainamide.

Authors:  E Karlsson; P Collste; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

2.  Efficacy of phenytoin in the management of ventricular arrhythmias induced by hypokalaemia.

Authors:  M V O'Reilly; R T MacDonald
Journal:  Br Heart J       Date:  1973-06

3.  Treatment of ventricular tachycardia in an infant.

Authors:  J Sanchez; K Christie; G R Cumming
Journal:  Can Med Assoc J       Date:  1972-07-22       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.